Cara Therapeutics achieves milestone payments from Japan and South Korea partners
Cara Therapeutics announced that it has earned a total of $2.5 million in milestone payments under its development and licensing agreements with Maruishi Pharmaceutical Company of Japan and Chong Kun Dang Pharmaceutical Corp. of South Korea. October 13, 2015